Research

Research highlights benefits of hemp-derived CBD reported by patients with anxiety: reduced anxiety, better sleep, and improved mood.

A new literature review highlights CBD’s potential in skin health, from acne to psoriasis, while exploring delivery challenges and future applications.

New research shows frequent cannabis users may drive as well as non-users after abstinence.

A UK Medical Cannabis Registry study found cannabis-based medicines improved sleep, anxiety, and quality of life in insomnia patients.

Clinical and in vitro analysis shows THC may impair female fertility, distrupting oocyte development and affecting IVF outcomes.

This month’s Healer webinar, led by Dustin Sulak, DO, explores new medical cannabis research including potential benefits for cancer, wound healing, ALS, Alzheimer’s, and terpenes like alpha-pinene.

An examination of survey data finds state cannabis laws strongly shape delta-8-THC use, with highest rates in prohibition states.

Here, we bring you our top five recent articles covering federal hemp ban, an interview with Reginald Gaudino, PhD, the reintroduced MORE Act, Delaware cannabis sales and rezoning, and restricting intoxicating hemp-derived cannabinoids.

Recent research highlights the potential of cannabinoids as alternative treatments for atopic dermatitis, showcasing their anti-inflammatory and antibacterial properties.

THC drinks are shaping a new drinking culture. A recent report dives into market growth, state regulations, and the challenges facing the industry.

As more studies are being conducted on multiple parts of the cannabis plant, this study tested the root samples against four cancer cell lines, finding evidence of antiproliferation effects.

Using an optimized analytical method for this research, the phenolics of cannabis were tested resulting in new findings.

Researchers investigated the role cannabis use may play in elevating the risk of kidney disease.

The FDA-funded study found that CBD was linked to elevated liver enzymes in some healthy adults, underscoring need for further safety research.

Here, we bring you our top four recent articles covering research on cannabinoids and sleep, why enrolled patients turn to illegal cannabis, using spent hemp biomass as livestock feed, and testing cannabinoids on breath after ingesting edibles.

The researchers measured the amount of THC and other cannabinoids on participants’ breaths, with results demonstrating an increase in THC concentration from baseline samples.

The exploratory analysis suggest that lower costs and reliable supply could affect reliance on illegal medical cannabis in Utah.

The study tracks how THC and CBD levels in cow milk, plasma, and fat tissue change during hemp feed intake and withdrawal periods.

In the second part of this webinar coverage, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.

Here, we bring you our top five recent articles covering National CBD Day 2025, medical cannabis patients’ workers’ compensation, Trump looking into cannabis rescheduling, research studies on cannabis for sleep, and a clinical trial for CBD and insomnia.

In this month’s webinar, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.

Avecho Biotechnology Limited is looking to recruit more than 500 patients for a clinical trial evaluating the use of a pharmaceutical CBD product to treat insomnia.

In honor of National CBD Day on August 8, 2025, we are excited to share with you our CBD-themed round up of CBD research.

Here, we bring you our top five recent articles covering multiple stories on adult-use cannabis sales in Delaware, the top compliance issues in 2025, and research on how medical cannabis affects healthcare utilization by chronic pain patients.

Analysis of two coffee products revealed 70–80% less CBD in the brewed coffee than what was indicated on the label.